Skip to main content

Table 1 Summary of the 14 pediatric cases of Exophiala dermatitidis infection reported in literature

From: Multidisciplinary management of disseminated Exophiala dermatitidis mycosis in an infant with mixed phenotype acute leukemia: a case report

No

Age

Gender

Clinical manifestation

Undelying disease

Susceptibility MIC (µg/mL)

Treatment

Outcome

References

1

6

F

Pneumonia

Cystic fibrosis

No data

ITCZ

Survive

[12]

2

5

M

Nosocomial intravascular infection

ALL

No data

ITCZ

Survive

[13]

3

3

M

Fungemia

ALL

No data

Catheter removal, AMB, 5-FC

Survive

[14]

4

3

M

Catheter-associated fungemia

HIV infection

No data

Catheter removal, AMB, ITCZ

Survive

[15]

5

3

M

Intracranial hypertension, paraplegia

None

No data

FLCZ, ITCZ, L-AMB

Death

[16]

6

11

F

Liver cirrhosis

None

AMB 1; ITCZ 0.064; VRCZ 0.016

VRCZ

Death

[17]

7

8

M

Systemic lymphadenitis

None

No data

AMB, VRCZ

Death

[18]

8

3

M

Cerebritis

None

No data

AMB, ITCZ, 5-FC

Death

[19]

9

8

M

Brain abscess

None

No data

AMB, VRCZ, 5-FC

Death

[20]

10

8

M

Pneumonia

AML

No data

PSCZ

Death

[21]

11

2

F

Catheter-related bloodstream infection

Retroperitoneal teratoma

AMB 0.5; FLCZ 4; ITCZ 0.25;

MCFG 2; VRCZ 0.12; 5-FC > 16

Catheter removal, L-AMB

Survive

[22]

12

4

F

Lymphadenitis, hemiparesis

Inherited CARD9 deficiency

No data

L-AMB, VRCZ

Survive

[23]

13

0.2

F

Catheter-associated fungemia

Mitochondriopathy

AMB 1; CPFG 2; FLCZ 4;

ITCZ ≤ 0.03; MCFG 2;

PSCZ 0.06; VRCZ ≤ 0.03; 5-FC 4

Catheter removal, FLCZ

Survive

[24]

14

0.2

M

Ecthyma gangrenosum, fungemia, pneumonia

MPAL

AMB 2; CPFG 0.25; FLCZ 8;

ITCZ 0.25; MCFG 1; VRCZ 0.12; 5-FC 4

CPFG, L-AMB, VRCZ, ELT, Surgery

Survive

Present case

  1. ALL acute lymphoblastic leukemia, AML acute myeloid leukemia, AMB amphotericin B, CPFG caspofungin, ELT ethanol lock therapy, FLCZ fluconazole, HIV human immunodeficiency virus, ITCZ itraconazole, L-AMB liposomal amphotericin B, MCFG micafungin, MPAL mixed-phenotype acute leukemia; PSCZ posaconazole, VRCZ voriconazole, 5-FC 5-fluorocytosine